GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Cash Flow for Lease Financing

Respiratorius AB (XSAT:RESP) Cash Flow for Lease Financing : kr0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Cash Flow for Lease Financing?

Respiratorius AB's Cash Flow for Lease Financing for the three months ended in Dec. 2024 was kr0.00 Mil. Respiratorius AB's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00 Mil.

Compared with last quarter (kr0.00 Mil in Sep. 2024 ), Respiratorius AB's Cash Flow for Lease Financing remained the same in Dec. 2024 (kr0.00 Mil).

Respiratorius AB Cash Flow for Lease Financing Historical Data

The historical data trend for Respiratorius AB's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiratorius AB Cash Flow for Lease Financing Chart

Respiratorius AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Respiratorius AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Respiratorius AB Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiratorius AB Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Respiratorius AB's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Respiratorius AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XSAT:PHAL XSAT:DBP B OSTO:NANECH OSTO:LPGO OSTO:SPRINT OSTO:STABL OSTO:QUIA OSTO:FLUI XSAT:APTA OSTO:SIMRIS B VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Website
https://www.respiratorius.com
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB Headlines

No Headlines